HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lu Wang Selected Research

Mesenchymal Chondrosarcoma

1/2022Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
2/2012Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lu Wang Research Topics

Disease

516Neoplasms (Cancer)
12/2022 - 01/2000
107Inflammation (Inflammations)
11/2022 - 12/2003
103Neoplasm Metastasis (Metastasis)
12/2022 - 06/2002
96Hepatocellular Carcinoma (Hepatoma)
12/2022 - 06/2002
68Infections
10/2022 - 04/2006
68Breast Neoplasms (Breast Cancer)
04/2022 - 02/2006
39Carcinogenesis
10/2022 - 11/2008
37Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 03/2009
33Pain (Aches)
05/2022 - 07/2009
31Obesity
07/2022 - 02/2006
31Hypertension (High Blood Pressure)
01/2021 - 01/2004
28Fibrosis (Cirrhosis)
10/2022 - 11/2007
28Carcinoma (Carcinomatosis)
01/2022 - 05/2003
27Insulin Resistance
07/2022 - 01/2004
27Stroke (Strokes)
03/2022 - 01/2011
27Wounds and Injuries (Trauma)
02/2022 - 07/2002
27Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2006
25Melanoma (Melanoma, Malignant)
03/2022 - 12/2009
24Lung Neoplasms (Lung Cancer)
07/2022 - 01/2002
24Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2004
23Neuroinflammatory Diseases
07/2022 - 01/2016
22Leukemia
10/2021 - 06/2004
21Body Weight (Weight, Body)
09/2022 - 09/2009
21Stomach Neoplasms (Stomach Cancer)
05/2022 - 01/2010
21Hypoxia (Hypoxemia)
09/2021 - 01/2006
20COVID-19
09/2022 - 01/2020
20Cognitive Dysfunction
01/2022 - 01/2013
19Alzheimer Disease (Alzheimer's Disease)
03/2022 - 11/2012
19Ischemic Stroke
01/2022 - 06/2018
18Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 06/2016
18Thrombosis (Thrombus)
05/2022 - 02/2003
18Sepsis (Septicemia)
03/2022 - 02/2013
17Type 2 Diabetes Mellitus (MODY)
03/2022 - 03/2006
17Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 11/2012
16Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 01/2012
16Schizophrenia (Dementia Praecox)
01/2022 - 09/2015
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 07/2002
15Necrosis
01/2021 - 08/2012
14Renal Cell Carcinoma (Grawitz Tumor)
08/2022 - 04/2014
14Esophageal Neoplasms (Esophageal Cancer)
01/2022 - 12/2012
13Glioma (Gliomas)
12/2022 - 10/2010
13Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 08/2013
13Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 08/2014
12Liver Neoplasms (Liver Cancer)
07/2022 - 07/2007
12Lymphatic Metastasis
02/2022 - 07/2007
12Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2013
12Heart Failure
01/2022 - 02/2011
12Infarction (Infarctions)
01/2022 - 03/2015
12Ischemia
11/2021 - 01/2013
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 01/2012
12Fatigue
01/2021 - 01/2008

Drug/Important Bio-Agent (IBA)

175Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2004
101Pharmaceutical PreparationsIBA
12/2022 - 01/2000
92Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2005
56Biological ProductsIBA
08/2022 - 04/2004
44MicroRNAs (MicroRNA)IBA
03/2022 - 01/2011
42CytokinesIBA
12/2022 - 10/2008
39Messenger RNA (mRNA)IBA
09/2022 - 06/2002
31DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2007
29RNA (Ribonucleic Acid)IBA
10/2022 - 03/2010
28Peptides (Polypeptides)IBA
12/2022 - 03/2007
28Therapeutic UsesIBA
07/2022 - 08/2012
27LipidsIBA
05/2022 - 01/2011
27Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2007
26Glucose (Dextrose)FDA LinkGeneric
10/2022 - 02/2011
26Long Noncoding RNAIBA
03/2022 - 01/2017
22Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 07/2003
19Small Interfering RNA (siRNA)IBA
02/2022 - 08/2010
18EnzymesIBA
02/2022 - 10/2008
18Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2012
18Insulin (Novolin)FDA Link
01/2022 - 02/2011
17salicylhydroxamic acid (SHAM)IBA
12/2022 - 10/2010
17CateninsIBA
10/2022 - 01/2014
16AntibodiesIBA
06/2022 - 04/2014
16CollagenIBA
01/2022 - 07/2002
16AntioxidantsIBA
01/2022 - 03/2006
16Indicators and Reagents (Reagents)IBA
01/2022 - 02/2008
15Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 08/2009
15Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 11/2014
14AntigensIBA
12/2022 - 07/2002
14LipopolysaccharidesIBA
03/2022 - 01/2017
14C-Reactive ProteinIBA
12/2021 - 02/2007
14Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2005
13LigandsIBA
04/2021 - 07/2005
13Phosphotransferases (Kinase)IBA
02/2019 - 12/2007
12CholesterolIBA
10/2022 - 09/2006
12Tyrosine Kinase InhibitorsIBA
09/2022 - 07/2011
12Neuroprotective AgentsIBA
03/2022 - 04/2019
12ErbB Receptors (EGF Receptor)IBA
10/2021 - 10/2010
12Fatty Acids (Saturated Fatty Acids)IBA
12/2020 - 07/2003

Therapy/Procedure

238Therapeutics
12/2022 - 01/2002
70Drug Therapy (Chemotherapy)
06/2022 - 08/2009
35Radiotherapy
02/2022 - 01/2002
20Stents
08/2022 - 01/2008
18Lasers (Laser)
05/2022 - 01/2015
18Photothermal Therapy
02/2022 - 01/2015
18Precision Medicine
01/2022 - 01/2015
17Immunotherapy
01/2022 - 07/2013
14Transplantation
01/2022 - 07/2002
12Aftercare (After-Treatment)
11/2021 - 10/2010